POLLENTYME S and Tabs Pharma Dynamics (Pty) Ltd Version: July 2017 (G1639) Word copy of G1639 PATIENT INFORMATION LEAFLET FOR POLLENTYME S AND TABS

Similar documents
PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET TEXAMER

PATIENT INFORMATION LEAFLET FOR TEXA 10 mg TABLETS AND TEXA SYRUP PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM:

PATIENT INFORMATION LEAFLET AMLOC RANGE

PATIENT INFORMATION LEAFLET DYNARB RANGE

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC.

PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET CARZIN XL

Read this entire leaflet carefully before you start taking DYNA BEZAFIBRATE. If you have further questions, please ask your doctor or your pharmacist.

PATIENT INFORMATION LEAFLET EFFERFLU C IMMUNE BOOSTER. EFFERFLU C IMMUNE BOOSTER has not been evaluated by the Medicines Control

PATIENT INFORMATION LEAFLET ZOXADON TABLETS RANGE

PATIENT INFORMATION LEAFLET SIMVACOR RANGE

PATIENT INFORMATION LEAFLET PEARINDA PLUS

PATIENT INFORMATION LEAFLET SINTAIR RANGE

PATIENT INFORMATION LEAFLET BILOCOR RANGE

PATIENT INFORMATION LEAFLET PEPLOC RANGE

Flecainide BNM. Please read this leaflet carefully before you start taking Flecainide BNM.

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

PATIENT INFORMATION LEAFLET FEDALOC RANGE

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops

Ceclor CD cefaclor monohydrate sustained release tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

PATIENT INFORMATION LEAFLET DYNAFIL RANGE

Consumer Medicine Information

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET CARVETREND RANGE

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

PATIENT INFORMATION LEAFLET ZYTOMIL RANGE

Consumer Medicine Information TOPICIL. Please read this leaflet carefully before you start using Topicil Capsules.

Ranitidine GH ranitidine hydrochloride film-coated tablets

Consumer Medicine Information. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

CONSUMER MEDICINE INFORMATION

PATIENT INFORMATION LEAFLET FOR FEDALOC 30 mg / 60 mg SR TABLETS. Please read this leaflet carefully before you start taking FEDALOC tablets.

MIDAZOLAM APOTEX Solution for Injection Contains the active ingredient midazolam

TRIPROLIDINE. Please read this leaflet and the packaging of the medicine you purchased, carefully before you start using triprolidine.

It does not take the place of talking to your doctor or pharmacist.

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)

SANDOMIGRAN. 0.5mg tablet Pizotifen malate

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

PHARMACY ACTION COLD & FLU DAY & NIGHT paracetamol, pseudoephedrine hydrochloride, chlorphenamine maleate

Chemmart Baclofen Tablets Contains the active ingredient baclofen

PATIENT INFORMATION LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

Consumer Medicine Information

PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam)

XYZAL 5 MG FILM-COATED TABLET

Package leaflet: Information for the user. Lorastad 10 mg Tablets loratadine

ZOLPIDEM PHARMACOR Zolpidem tartrate

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

Colofac mebeverine hydrochloride

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

All medicines have risks and benefits. Your doctor has weighed the risks of you taking Triprim against the benefits he or she expects it will have.

APO-Diazepam Tablets Contains the active ingredient diazepam (dye-az-e-pam)

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide

Consumer Medicine Information

PATIENT INFORMATION LEAFLET: Lancap 15 mg and 30 mg. Please read this leaflet carefully before taking LANCAP capsules.

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

Simplotan* tablets Tinidazole (tin-id-azole)

This leaflet answers some of the common questions people ask about Pharmacor Omeprazole.

Before you take it. When you must not take it

VACLOVIR. What is in this leaflet. What VACLOVIR is used for. for Herpes Zoster and Herpes Labialis valaciclovir (as hydrochloride)

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets

Package leaflet: Information for the user. Burinex 5 mg Tablets bumetanide

APO-Ondansetron Contains the active ingredient, ondansetron (as hydrochloride dihydrate)

1. What Betahistine dihydrochloride tablets is and what it is used for

Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium)

PATIENT INFORMATION LEAFLET

This leaflet answers some of the common questions people ask about Pharmacor Omeprazole.

Package leaflet: Information for the user. Pravastatin Actavis 20 mg and 40 mg tablets (pravastatin sodium)

How Entecavir GH Works

BOSLEER CONSUMER MEDICINE INFORMATION

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops

What is in this leaflet

TRAMAL SR Sustained Release Tablets

Clarinase Loratadine and Pseudoephedrine Sulfate

Valaciclovir generichealth Treatment of herpes simplex

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

PHOLCODINE. Please follow the instructions on the packaging of the medicine you purchased and in this leaflet before you start using pholcodine.

PACKAGE LEAFLET: INFORMATION FOR THE USER. BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE

This leaflet answers some common questions about ATIVAN. It does not contain all of the available information.

PREGABALIN APOTEX contains the active ingredient pregabalin

CONSUMER MEDICINE INFORMATION (CMI) It does not take the place of talking to your pharmacist or doctor.

PATIENT INFORMATION LEAFLET BILOCOR CO RANGE

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Leflunomide APOTEX Tablets Leflunomide

Bisacodyl Laxative (Pharmacy Health)

Before you take this medicine. When you must not take it

Day Cold & Flu Relief Oral Solution (Paracetamol, Pholcodine, Pseudoephedrine Hydrochloride)

Blooms The Chemist Pregabalin

APOHEALTH Diarrhoea Relief PLUS

Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR

CONSUMER MEDICINE INFORMATION

Transcription:

PROPOSED FINAL PATIENT INFORMATION LEAFLET FOR POLLENTYME TABLETS & POLLENTYME S PATIENT INFORMATION LEAFLET SCHEDULING STATUS: S1 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: POLLENTYME TABLETS (tablets) POLLENTYME S (syrup) Read all of this leaflet carefully because it contains important information for you POLLENTYME is available without a doctor s prescription, for you to treat a mild illness. Nevertheless you still need to use POLLENTYME carefully to get the best results from it. Keep this leaflet. You may need to read it again. Do not share POLLENTYME with any other person. Ask your pharmacist if you need more information or advice. You must see a doctor if your symptoms worsen or do not improve. 1. WHAT POLLENTYME CONTAINS: POLLENTYME TABLETS The active substance is: Each POLLENTYME TABLET contains 10 mg loratadine (micronized). The other Ingredients are: Lactose monohydrate, magnesium stearate, maize starch and microcrystalline cellulose. POLLENTYME TABLETS contain sugar in the form of lactose monohydrate. Response to CCR dated 11 May 2016 page 1 of 9

POLLENTYME S: The active substance is: Each 5 ml of POLLENTYME S contains 5 mg loratadine (micronized). The other Ingredients are: Citric acid monohydrate, glycerol, peach flavour, propylene glycol, 0,1 % m/v sodium benzoate (as preservative), purified water. POLLENTYME S contains sugar (sucrose). 2. WHAT POLLENTYME IS USED FOR: POLLENTYME tablets or syrup are used to relieve allergy symptoms such as sneezing, runny nose and itchy, burning eyes whether these are due to hay fever or whether they occur all year round. POLLENTYME tablets or syrup may also be taken for allergic skin conditions such as rash, itching or urticaria (hives). 3. BEFORE YOU TAKE POLLENTYME: Do not take POLLENTYME: If you are hypersensitive (allergic) to loratadine or any other ingredients of POLLENTYME (see WHAT POLLENTYME CONTAINS). If you are hypersensitive (allergic) to antihistamines (medicines used in the treatment of allergy). If you have a liver disease Safety of POLLENTYME in the elderly has not been established. Response to CCR dated 11 May 2016 page 2 of 9

Take special care with POLLENTYME POLLENTYME may cause some drowsiness. If you drink alcohol or take other central nervous system depressants (sedatives or tranquilisers) whilst taking POLLENTYME you may experience unwanted side effects. If you are an elderly person you may experience dizziness, sleepiness, dry mouth or difficulty with urination. Take caution when using POLLENTYME tablets or syrup. When POLLENTYME is taken for extended periods, side effects including dry mouth, tooth decay, tooth crumbling, swelling and redness of the gums, yeast infection in the mouth (oral thrush) and general mouth discomfort, may be experienced. POLLENTYME should not be given to babies and children younger than 2 years of age. If you have liver disease. If you are scheduled to undergo any tests for skin allergies you should not take POLLENTYME for 2 days before the tests as it may affect the test results (see Taking other medicines). Your doctor may request tests to monitor your condition before or during treatment. Taking POLLENTYME with food and drink: POLLENTYME can be taken with or without food. Pregnancy and Breastfeeding: If you are pregnant or breastfeeding your baby, please consult your doctor, pharmacist or other healthcare professional for advice before using POLLENTYME. Response to CCR dated 11 May 2016 page 3 of 9

Driving and using machinery: POLLENTYME may impair your ability to drive and use machinery. Do not drive, operate machinery, or do anything else that could be dangerous until you know how POLLENTYME affects you. Important information about some of the ingredients of POLLENTYME: POLLENTYME TABLETS contain lactose. Patients with the rare hereditary conditions of lactose or galactose intolerance should not take POLLENTYME TABLETS. POLLENTYME TABLETS contains lactose which may have an effect on the control of your blood sugar if you have diabetes mellitus. POLLENTYME S contains sucrose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking POLLENTYME S. POLLENTYME S contains sucrose which may have an effect on the control of your blood sugar if you have diabetes mellitus. Taking other medicines with POLLENTYME: Always tell your healthcare professional if you are taking any other medicine. (This includes complementary or traditional medicines.) Do not use the following medicines in combination with POLLENTYME: Sleeping tablets, used in the treatment of sleeping disturbances. Tricyclic antidepressants or an antidepressant containing maprotiline, used in the treatment of depression. Do not consume alcohol when you are on POLLENTYME treatment. Response to CCR dated 11 May 2016 page 4 of 9

If you have to go for an allergy skin test, stop using POLLENTYME several days before, as it may influence the results of the test (see Take special care). Erythromycin, used to treat bacterial infections. Fluconazole, itraconazole, ketoconazole, metronidazole or miconazole, used to treat fungal infections. Quinidine, used to treat heart rhythm conditions. Cimetidine, used to treat indigestion and stomach ulcers. Medicines that can cause temporary hearing loss may mask side effects such as dizziness or ringing in the ears. Medicines that cause sensitivity of the skin may mask the side effects of light sensitivity. 4. HOW TO TAKE POLLENTYME: Do not share medicines prescribed for you with any other person. Always take POLLENTYME exactly as your doctor has instructed you. You should check with your doctor or pharmacist if you are unsure. The usual dosages are as follows: POLLENTYME TABLETS: Adults and children over the age of 12 years: One tablet once a day. POLLENTYME S: Adults and children over the age of 12 years: 10 ml (2 medicine measures) once a day. Response to CCR dated 11 May 2016 page 5 of 9

Children 2 to 12 years: Body weight less than 30 kg: 5 ml (1 medicine measure) once a day. Body weight more than 30 kg: 5 ml (1 medicine measure) twice a day. If you take more POLLENTYME than you should In the event of overdosage, consult your doctor or pharmacist immediately. If neither is available, contact the nearest hospital or poison control centre. Take this leaflet and any remaining tablets or syrup with you, so that the doctor knows what you have taken. If you forget to take POLLENTYME: If you forget to take your medicine, take your recommended dose as soon as you remember. Do not take a double dose to make up for forgotten individual doses. 5. POSSIBLE SIDE EFFECTS: POLLENTYME can have side effects. Not all side effects reported for POLLENTYME are included in this leaflet. Should your general health worsen, or if you experience any untoward effects while taking POLLENTYME please consult your doctor, pharmacist or other healthcare professional for advice. If any of the following happens, stop taking POLLENTYME and tell your doctor immediately or go to the casualty department at your nearest hospital: swelling of the hands, feet, ankles, lips, mouth or throat which may cause difficulty in breathing rash or itching These are all very serious side effects. If you have them, you may have had a serious allergic reaction to POLLENTYME. You may need urgent medical attention or hospitalisation. Response to CCR dated 11 May 2016 page 6 of 9

Tell your doctor immediately or go the casualty department at your nearest hospital if you notice any of the following: Increased, irregular or fast heart beat (tachycardia). Low blood pressure Hepatitis (inflammation of the liver with symptoms such as nausea, mild fever, abdominal pain). Convulsions (fits) These are all serious side effects. You may need urgent medical attention. Tell your doctor if you notice any of the following: abnormal blood test results including anaemia tremors, sweating abnormal coordination (jerky and unsteady movements) dizziness, drowsiness feeling depressed, sleep disorders, confusion increased appetite or loss of appetite abnormal liver function (clay coloured stool, dark urine, itching, loss of appetite, yellow eyes or skin) difficulty in passing urine, pain when passing urine tingling sensation in hands, feet or lips (feeling of pins and needles ) nausea, vomiting stomach pain or discomfort, inflammation of the stomach diarrhoea dry mouth, nose or throat muscle pain Response to CCR dated 11 May 2016 page 7 of 9

skin rash, sensitivity to light, dry skin, hair loss blurred vision, worsening eyesight ringing or buzzing in the ears extreme tiredness. If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist. 6. STORING AND DISPOSING OF POLLENTYME: Store all medicines out of reach of children. Store in a cool (at or below 25 C), dry place. Do not remove from the outer carton until required for use. Do not use after the expiry date printed on the label or carton. Return all unused medicine to your pharmacist. Return any expired or unused medicine to your pharmacist for safe disposal. Do not dispose of unused medicine in drains or sewerage systems (e.g. toilets). 7. PRESENTATION OF POLLENTYME: POLLENTYME TABLETS: Clear, colourless PVC/aluminium blister strips of 10 tablets. Packs of 10 and 30 tablets contained in printed outer cartons. POLLENTYME S: Brown (amber) glass bottles of 100 ml and 150 ml, white polypropylene screw cap and measuring cup. Bottles are packed into printed outer cartons. Response to CCR dated 11 May 2016 page 8 of 9

8. IDENTIFICATION OF POLLENTYME: POLLENTYME TABLETS: White or almost white, round, flat tablet scored on one side. POLLENTYME S: Clear to yellowish syrup, free from any visible particulate matter, with a characteristic peach flavour and odour. Response to CCR dated 11 May 2016 page 9 of 9